Your browser doesn't support javascript.
loading
Delineation of the clinical profile of CNOT2 haploinsufficiency and overview of the IDNADFS phenotype.
Niceta, Marcello; Pizzi, Simone; Inzana, Francesca; Peron, Angela; Bakhtiari, Somayeh; Nizon, Mathilde; Levy, Jonathan; Mancini, Cecilia; Cogné, Benjamin; Radio, Francesca Clementina; Agolini, Emanuele; Cocciadiferro, Dario; Novelli, Antonio; Salih, Mustafa A; Recalcati, Maria Paola; Arancio, Rosangela; Besnard, Marianne; Tabet, Anne-Claude; Kruer, Michael C; Priolo, Manuela; Dallapiccola, Bruno; Tartaglia, Marco.
Affiliation
  • Niceta M; Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Pizzi S; Department of Pediatrics, Sapienza University, Rome, Italy.
  • Inzana F; Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Peron A; Genetic Counseling Service, Regional Hospital of Bolzano, Bolzano, Italy.
  • Bakhtiari S; Medical Genetics, ASST Santi Paolo e Carlo, Ospedale San Paolo, Milan, Italy.
  • Nizon M; Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
  • Levy J; Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
  • Mancini C; Departments of Child Health, Neurology, and Cellular and Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.
  • Cogné B; CHU Nantes, Service de Génétique Médicale, L'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.
  • Radio FC; Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.
  • Agolini E; Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Cocciadiferro D; Laboratoire de Génétique Moléculaire, CHU de Nantes, Nantes, France.
  • Novelli A; Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Salih MA; Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Recalcati MP; Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Arancio R; Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Besnard M; Neurology Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Tabet AC; Department of Pediatrics, College of Medicine, Almughtaribeen University, Khartoum, Sudan.
  • Kruer MC; Medical Cytogenetics Laboratory, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Italy.
  • Priolo M; Clinica Pediatrica, Ospedale San Paolo, ASST Santi Paolo Carlo, Milan, Italy.
  • Dallapiccola B; Service de Néonatologie, Centre Hospitalier de Polynésie Française, Papeete, French Polynesia.
  • Tartaglia M; Human Genetics and Cognitive Functions, Institut Pasteur, UMR3571 CNRS, Université de Paris, Paris, France.
Clin Genet ; 103(2): 156-166, 2023 02.
Article in En | MEDLINE | ID: mdl-36224108
ABSTRACT
CNOT2 haploinsufficiency underlies a rare neurodevelopmental disorder named Intellectual Developmental disorder with NAsal speech, Dysmorphic Facies, and variable Skeletal anomalies (IDNADFS, OMIM 618608). The condition clinically overlaps with chromosome 12q15 deletion syndrome, suggesting a major contribution of CNOT2 haploinsufficiency to the latter. CNOT2 is a member of the CCR4-NOT complex, which is a master regulator of multiple cellular processes, including gene expression, RNA deadenylation, and protein ubiquitination. To date, less than 20 pathogenic 12q15 microdeletions encompassing CNOT2, together with a single truncating variant of the gene, and two large intragenic deletions have been reported. Due to the small number of affected subjects described so far, the clinical profile of IDNADFS has not been fully delineated. Here we report five unrelated individuals, three of which carrying de novo intragenic CNOT2 variants, one presenting with a multiexon intragenic deletion, and an additional case of 12q15 microdeletion syndrome. Finally, we assess the features of IDNADFS by reviewing published and present affected individuals and reevaluate the clinical phenotype of this neurodevelopmental disorder.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurodevelopmental Disorders / Intellectual Disability Limits: Humans Language: En Journal: Clin Genet Year: 2023 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurodevelopmental Disorders / Intellectual Disability Limits: Humans Language: En Journal: Clin Genet Year: 2023 Document type: Article Affiliation country: Italia
...